Picture of MiMedx logo

MDXG MiMedx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

MiMedx Group Inc expected to post a loss of 9 cents a share - Earnings Preview

* MiMedx Group Inc  MDXG.OQ   MDXG.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 2. 
    * The Marietta Georgia-based  company is expected to report 
a
8.9% increase in revenue to $64.15 million from $58.89 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for MiMedx Group Inc is
for a
loss of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for MiMedx
Group Inc
is $9​, above​ its last closing price of $3.65. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.04       -0.04      -0.02     Beat    45.5
 Sep. 30 2022  -0.07       -0.08      -0.09     Missed  -16.1
 Jun. 30 2022  -0.05       -0.06      -0.11     Missed  -94.1​
 Mar. 31 2022  -0.10       -0.10      -0.11     Missed  -10
 ​​Dec.        -0.02       -0.03      0.01      Beat    130
 31 2021                                                
 Sep. 30 2021  -0.08       -0.08      -0.04     Beat    50​
 Jun. 30 2021  -0.08       -0.07      -0.03     Beat    59.1
 Mar. 31 2021  -0.19       -0.19      -0.09     Beat    52.6
 This summary was machine generated April 28 at 20:29 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on MiMedx

See all news